SCHEMBL29909044

SCHEMBL29909044

CN(c1cc(F)cc(C#CC2CC2)c1)c1nc2nncn2c2ccc(F)cc12

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.33
GSK3B P49841 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23577453 1.00 MAPT (0.33) MAPTGSK3B
SCHEMBL23577280 0.90 ABCG2 (0.33) MAPTGSK3B
SCHEMBL29909299 0.90 ABCG2 (0.33) MAPTGSK3B
SCHEMBL29909404 0.85 MAPT (0.30) MAPT
SCHEMBL23577331 0.85 MAPT (0.30) MAPT
SCHEMBL23576948 0.83
SCHEMBL29909026 0.83
SCHEMBL23576975 0.83
SCHEMBL23601439 0.83 PER2 (0.31)
SCHEMBL29909855 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4081305-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS Carna Biosciences, Inc. (JP) 2022-11-02 EP disclosed